Week in Review: Grupo Insud to Build China Veterinary Drug Facility
Grupo Insud of Argentina will spend $55 million to build an animal health manufacturing plant in China; Guangzhou Pharma Co. will acquire the assets of Guangzhou Baiyunshan Pharma; Roche opened a sales headquarters in Chengdu to build its Western China revenues; Essex Woodlands, a US growth capital firm, announced a new office in Shanghai to invest in China healthcare companies; Covance’s Shanghai lab was granted a GLP Certificate by the SFDA; Neusoft Medical Systems, a China medical imaging company, received approval for US sales of its NeuViz 64 multi-slice CT scanner; and Edwards Lifesciences (NYSE: EW) was given SFDA approval for its bovine-based replacement heart valve. More details.... Stock Symbols: (SHA: 600332) (SHE: 000522) (VS: ROG) (NYSE: CVD) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here